In this episode of Hands of Change, we feature Dr. Keith Denkler, a leading expert in Dupuytren’s disease treatment with over 10,000 fingers treated and member of our Scientific Advisory Board. Dr. Denkler shares his expertise in minimally invasive techniques for Dupuytren’s contracture, offering valuable insights into the latest advancements, expert advice, and tips for patients. https://lnkd.in/gyC9QCbr #dupuytrens #handsurgery #innovation
Ventoux Biosciences
生物技术研究
Encinitas，California 372 位关注者
Transforming treatment for Dupuytren's and related, under-served, immune-fibrotic diseases
关于我们
Ventoux Biosciences is working to transform treatment for Dupuytren’s and related, under-served, immuno-fibrotic diseases. Founded by a Dupuytren’s patient and propelled by a team with Dupuytren's and fibrosis expertise from bench to bedside – we seek to revolutionize current treatment options via development of novel, first-line, disease-modifying, non-surgical options for patients. Dupuytren's is a chronic, progressive, debilitating and often painful fibrosis of the hands and is >3x more prevalent than Rheumatoid Arthritis. However; no cure and no approved disease slowing agents exist. Unlike RA, surgery remains as the standard of care for Dupuytren's patients. Following positive anti-fibrotic data in an established scleroderma / dermal fibrosis model, we are working to advance our lead candidate VEN-201 to human studies. Our business strategy is to expedite treatment for patients by leveraging expedited FDA clinical & regulatory pathways. Dupuytren's impacts ~265m patients across 7 major markets and upwards of 10 million patients in the U.S. alone. VEN-201 represents a potential novel, differentiated, first-line treatment to slow disease progression and help patients maintain hand function and delay potential progression to surgery or surgical interventions.
- 网站
-
https://www.ventouxbio.com/
Ventoux Biosciences的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Encinitas，California
- 类型
- 私人持股
- 创立
- 2022
- 领域
- Fibrosis、Inflammation、Auto-Immune、Dupuytren's Disease、Ledderhose Disease和Patient Focused
地点
-
主要
获取路线
315 S Coast Highway 101
US，California，Encinitas
Ventoux Biosciences员工
动态
-
This week, we're pausing to reflect on gratitude. While Thanksgiving is a U.S. tradition, the spirit of thankfulness transcends borders. We're grateful for our global community—patients, researchers, and providers—who inspire progress every day. #gratitude #thankful
-
-
Ilse Degreef, MD, PhD joined the "Hands of Change" podcast to discuss Dupuytren's disease, her extensive research and dedication to novel surgical techniques. Listen on all major podcast platforms.
Wonderful to have Dr. Ilse Degreef join the "Hands of Change" Podcast. From Professor Degreef's innovative Dupuytren's research to the advancement of novel surgical techniques to improve outcomes, she is driving positive change for this debilitating disease.
-
We are pleased to share updates on our progress in Dupuytren's disease, pre-clinical evidence for VEN-201, and go forward plans. Our webinar replay is available via the link below or our website. Thank you. https://lnkd.in/gq-JbyQt
Dupuytren's Disease and the Potential for VEN-201 - Ventoux Biosciences
https://www.youtube.com/
-
Join Anna as she shares her personal experiences with Dupuytren's, Ledderhose, and Adhesive Capsulitis. Hear about her treatments, future possibilities, and the founding of the British Dupuytren's Society, along with their patient support and global partnerships. https://lnkd.in/gKyMZgGp
Championing Change: Anna Schurer on Co-Founding & Leading the British Dupuytren's Society, Advocacy, and Living with the Disease
podbean.com
-
We will be holding our first company webinar next week. Plan to share updates on the team, our progress, and our plans for VEN-201, as well as answer some questions. Please register and join if you are interested. We plan to make a re-play available as well following the session. Thank you. https://lnkd.in/g6P9tHNt
-
The Hand's of Change Podcast features patients, researchers, and care providers focused on Dupuytren's and related immune-fibrotic diseases. Episode 3 features special guest Kathy Redmond who has the unique experience of serving as a voice for patients and a patient ambassador in her professional life while also living with Dupuytren's. Find the show and this episode, as well as links to all major podcast platforms, via the "Hands of Change" podcast website. Ventoux Biosciences is a proud sponsor of the "Hands of Change" podcast and is hosted by Kurt Harrington. https://lnkd.in/gsU55UVV
-
Thank you PharmaShots for the interview and the opportunity to share more about our progress and plans for VEN-201 in Dupuytren's and related immune-fibrotic diseases. #fibrosis #immunology #dupuytrens Kurt Harrington